Humana drug alerts.

Drug Recalls, Alerts, and New Therapies

This page is your source for pharmacy-related safety alerts, drug recalls, new therapies and generics, and other medication information.

Drug alerts

03/26/2013
Generic Suboxone Available
Suboxone is now available as a generic.
(93 KB) Download PDF
English
03/26/2013
Atorvastatin Drug Recall
The manufacturer of atorvastatin has issued a voluntary recall of certain lots of this medicine.
(25 KB) Download PDF
English
03/26/2013
Pradaxa Drug Recall
The manufacturer of Pradaxa is recalling one lot of Pradaxa due to a potential packaging defect.
(128 KB) Download PDF
English
09/14/2012
Actos and ActoPlus Met are available as generics (pioglitazone and pioglitazone/metformin)
We want to let you know Actos and ActoPlus Met are now available as generics, pioglitazone and pioglitazone/metformin. Actos and the combination drug ActoPlus Met are used to treat patients with type 2 diabetes.
(166 KB) Download PDF
English
09/14/2012
Packages of Nimodipine Capsules, 30 mg Recalled
The manufacturer of Nimodipine is recalling certain packages of the medicine due to the discovery that some capsules may contain crystallized material.
(77 KB) Download PDF
English
08/24/2012
Singulair is available as a generic (montelukast)
We want to let you know Singulair is now available as a generic. Singulair treats asthma and allergies.
(165 KB) Download PDF
English
08/24/2012
Detrol is available as a generic (tolterodine)
We want to let you know Detrol is now available as a generic. Detrol treats patients with overactive bladder. Ask your doctor or pharmacist if the generic, tolterodine, is right for you.
(167 KB) Download PDF
English
06/15/2012
Introvale (levonorgestrel and ethinyl estradiol) Packages Recalled
The manufacturer of Introvale is recalling certain packages of the medicine due to the discovery that the active pills (which are a peach color) and placebo pills (which are white) in some packs may be in the wrong order.
(98 KB) Download PDF
English
6/8/2012
Gilenya (fingolimod) Can Cause Serious Side Effects, Including Slow Heart Rate
According to the U.S. Food and Drug Administration (FDA), using Gilenya (fingolimod) can cause serious side effects such as slow heart rate (bradycardia), which can lead to dizziness, fatigue, and heart palpitations. Gilenya is a medicine that is used to treat relapsing forms of multiple sclerosis, also known as MS.
(150.61 KB) Download PDF
English
06/01/2012
Plavix is Available as a Generic (Clopidogrel)
Plavix is now available as a generic called clopidogrel. Plavix is used to help prevent blood platelets from forming clots in people who have heart disease or poor circulation, usually in the legs (also called peripheral artery disease). Plavix is also prescribed to people who have had a recent heart attack or stroke.
(166.50 KB) Download PDF
English
05/25/2012
Certain Packages of Hydromorphone Injection Recalled
Certain packages of hydromorphone injection USP, 1 mg/mL, 1 mL fill in 2.5 mL Carpuject have been recalled by its manufacturer, Hospira Inc.
(77 KB) Download PDF
English
05/04/2012
Certain packages of morphine sulfate injection USP, 4 mg/mL, 1 mL fill recalled
The manufacturer of morphine sulfate injection is recalling certain packages of the medicine due to a consumer report of two Carpuject syringes that had more than 1 mL of morphine sulfate.
(76 KB) Download PDF
English
04/19/2012
FDA Revises Safety Labels for Statins
The U.S. Food and Drug Administration (FDA) revised the safety labels on statins, a class of medicines aimed at lowering cholesterol. The new information includes: memory loss and confusion have been reported with statin use; increases in blood sugar levels have been reported with statin use; liver enzyme tests should be performed before starting statin therapy and as recommended by your doctor.
(150 KB) Download PDF
English
04/19/2012
Aliskiren Products (Tekturna®, Tekturna HCT®, Takamlo®, Valturna® and Amturnide®) No Longer Recommended for Diabetic Patients also on an ACEI or ARB
The use of medicines that contain aliskiren with an ACEI or ARB can increase the risk of kidney problems, low blood pressure, and increased potassium levels.
(27 KB) Download PDF
English
03/05/2012
Packages of Norgestimate and Ethinyl Estradiol Recalled
The manufacturer of norgestimate and ethinyl estradiol is recalling certain packages of the medicine due to the discovery that some packs may have tablets that are out of sequence.
(112 KB) Download PDF
English
03/01/2012
Proton Pump Inhibitors (PPIs) May Increase Risk of Clostridium difficile-Associated Diarrhea (CDAD)
According to the U.S. Food and Drug Administration (FDA), using proton pump inhibitors (PPIs) may increase the risk of Clostridium difficile-associated diarrhea (CDAD).
(27 KB) Download PDF
English
03/01/2012
FDA Issues Warning about Counterfeit Avastin®
According to the U.S. Food and Drug Administration (FDA), a counterfeit version of Avastin 400 mg/16 mL may have been bought and administered in 19 medical practices in the United States.
(26 KB) Download PDF
English
02/20/2012
Vials of Acetylcysteine Solution 20%, 30 mL Recalled
Lot Number 1877093 of acetylcysteine solution 20%, 30 mL vials has been recalled by its manufacturer due to the discovery of a visible glass particle in a vial within this lot.
(24 KB) Download PDF
English
02/10/2012
Norvatis Consumer Health suspends production of Endo Pharmaceuticals products Opana® ER, Opana®, oxymorphone hydrochloride, Percocet®, Percodan®, Endocet®, Endodan®, morphine sulfate extended–release, and Zydone®.
The manufacturer of Opana® ER, Opana®, oxymorphone hydrochloride, Percocet®, Percodan®, Endocet®, Endodan®, morphine sulfate extended–release, and Zydone® is suspending production due to a potential product mix-up in which tablets from one medicine may have been placed into packaging of another medicine.
(184 KB) Download PDF
English
02/10/2012
Pfizer Inc. recalls packages of Lo/Ovral®-28 and norgestrel/ethinyl estradiol.
The manufacturer of Lo/Ovral®-28 and norgestrel/ethinyl estradiol is recalling certain packages of the medicine due to the discovery that some packs may have the wrong number of active and inactive ingredient tablets and that the tablets may be out of sequence.
(110 KB) Download PDF
English
11/17/2011
Zyprexa® is now available as a generic.
(169 KB) Download PDF
English
11/1/2011
According to the U.S. Food and Drug Administration (FDA), Avandia (a rosiglitazone-containing product), will no longer be dispensed through your local pharmacy effective November 18, 2011.
(150 KB) Download PDF
English
10/13/2011
According to the U.S. Food and Drug Administration (FDA), using repackaged Avastin® (bevacizumab) for eye injections can cause serious eye infections in rare cases.
(32 KB) Download PDF
English
10/13/2011
According to the FDA, using the antidepressant Celexa can lead to a rare ventricular tachycardia.
(32 KB) Download PDF
English
10/13/2011
According to the FDA, using Reclast can lead to severe kidney failure in rare cases.
(32 KB) Download PDF
English
8/19/2011
According to the U.S. Food and Drug Administration (FDA), using Zyvox (linezolid) and psychiatric medications affecting serotonin levels, can cause side effects.
(26 KB) Download PDF
English
8/11/2011
Arixtra® is now available as a generic
(165 KB) Download PDF
English
8/11/2011
Tamiflu® May Cause Side Effects
(166 KB) Download PDF
English
8/11/2011
Valproate Medications May Cause Side Effects
(152 KB) Download PDF
English
7/28/2011
Possible side effects of using Erythropoiesis-Stimulating Agents
According to the FDA, using Erythropoiesis-Stimulating Agents such as Procrit®, Epogen®, or Aranesp® for the treatment of anemia in patients with chronic kidney disease can cause an increased risk of harmful side effects.
(148 KB) Download PDF
English
7/15/2011
Recall of some butalbital, acetaminophen and caffeine tablets
The manufacturer of butalbital, acetaminophen and caffeine tablets is recalling some bottles of this medicine after a single bottle of tablets was found incorrectly labeled.
(23 KB) Download PDF
English
7/15/2011
Recall of some Endocet® 10/325 mg tablets
The manufacturer of Endocet® 10/325 mg tablets is recalling some bottles of this medicine because some bottles may contain different strength tablets.
(26 KB) Download PDF
English
7/15/2011
Recall of some hydrocodone and acetaminophen tablets
The manufacturer of hydrocodone and acetaminophen tablets is recalling some bottles of this medicine after a single bottle of tablets was found incorrectly labeled.
(23 KB) Download PDF
English
7/15/2011
The FDA says Simvastatin (Zocor) 80mg may cause muscle injury.
(105 KB) Download PDF
English
6/24/2011
Ropinirole 1 mg tablets recalled
One lot of Ropinirole 1 mg tablets tablets has been recalled by its manufacturer CorePharma LLC.
(23 KB) Download PDF
English
6/24/2011
Glyburide 2.5 mg tablets recalled
One lot of Glyburide 2.5 mg tablets tablets has been recalled by its manufacturer CorePharma LLC.
(23 KB) Download PDF
English
5/20/2011
Allegra® and Allegra-D® are now available without a prescription
Allegra® (fexofenadine) and Allegra-D® (fexofenadine/pseudoephedrine) are now available over-the-counter (OTC) and may be purchased without a prescription.
(39 KB) Download PDF
English
5/20/2011
Important Recall Notice Regarding using tumor necrosis factor (TNF) blockers
According to the U.S. Food and Drug Administration (FDA), using tumor necrosis factor (TNF) blockers (medicines like Humira®, Enbrel®, Simponi®, Cimzia®, Remicade®) , azathioprine, and/or mercaptopurine can cause side effects.
(32 KB) Download PDF
English
5/20/2011
Important Recall Notice Regarding Coumadin
One lot number of Coumadin 5 mg tablets has been recalled by its manufacturer, Bristol-Myers Squibb because a single tablet was found to be higher in potency than expected.
(28 KB) Download PDF
English
4/28/2011
PPI extended usage causes unwanted side effects
According to the U.S. Food and Drug Administration (FDA), using Proton Pump Inhibitors (Nexium, Prevacid, Prilosec, etc) for an extended period of time may cause low magnesium levels.
(32 KB) Download PDF
English
4/28/2011
Xalatan now is available in generic form-latanoprost.
Xalatan®, a drug approved to help with the treatment of glaucoma, is now available as a generic, latanoprost.
(57 KB) Download PDF
English
4/15/2011
Auralgan Otic Solution Removed From The Market
The FDA notified companies that make, ship, or sell Auralgan Otic Solution to stop. This is because the medicine does not have FDA approval and its labeling does not include adequate directions. This means Auralgan Otic Solution will no longer be available.
(57 KB) Download PDF
English
01/01/11
Hydrocodone, Acetaminophen, and Phenobarbital Removed from Market
Qualitest Pharmaceuticals issued a voluntary nationwide recall of hydrocodone and acetaminophen tablets 10mg / 500mg and phenobarbital tablets 32.4 mg. An individual bottle of hydrocodone and acetaminophen tablets, 10mg / 500mg, 60 count was found incorrectly labeled with a phenobarbital tablets 32.4mg, 1000 count label.
(69 KB) Download PDF
English
12/30/10
Generic Colchicine Removed From Market
This change happened because of a ruling by the U.S. Food and Drug Administration (FDA).
(30 KB) Download PDF
English
12/30/10
Propoxyphene Removed From Market
This change happened because of a ruling by the U.S. Food and Drug Administration (FDA).
(29 KB) Download PDF
English
11/04/2010
Fentanyl Transdermal Patches Recalled by Actavis
Actavis is voluntarily recalling 18 lots of Fentanyl transdermal system 25 mcg/h.
(35 KB) Download PDF
English
10/16/2010
Important Recall Notice Regarding Methotrexate Injection
Sandoz Inc. is voluntarily recalling all 50mg/2mL and 250mg/10mL vials of Sandoz and Parenta brand Methotrexate Injection. Please read the attached for more information about this recall and further instructions.
(50 KB) Download PDF
English
10/1/2010
A generic is now availble for StratteraTM
A generic is now available for Strattera. If you currently take Strattera and choose the generic alternative, your cost may be lower. Ask your doctor or pharmacist whether Atomoxetine (generic name of brand name Strattera) would be right for you.
9/28/2010
U.S. FDA issues a warning regarding possible link between the use of ARBs and a small increased risk of cancer.
On July 15, the U.S. Food and Drug Administration (FDA) issued a warning regarding a possible link between the use of angiotensin receptor blockers (ARBs) and a small increased risk of cancer based upon a recently published meta-analysis in Lancet Oncology. ARBs have been widely used since the approval of Cozaar® (losartan) in 1995. Currently seven ARBs are available, including Atacand® (candesartan), Avapro® (irbesartan), Benicar® (olmesartan), Cozaar (losartan), Diovan® (valsartan), Micardis® (telmisartan), and Teveten® (eprosartan).If you are currently taking a ARB, the FDA believes that ARB use is of significant benefit in disease states such as hypertension and heart failure, and recommends that ARBs continue to be used as recommended per approved manufacturer labels. To date, the FDA has not concluded that ARBs increase the risk of cancer.
7/1/2010
Pfizer Inc. has announced the voluntary withdrawal from the U.S. market of the drug Mylotarg
(30 KB) Download PDF
English
3/18/2010
LifeScan is voluntarily recalling Test Strips
LifeScan is voluntarily recalling eight lots of OneTouch® SureStep® Test Strips.
(37 KB) Download PDF
English
3/4/2010
OneTouch SureStep Test Strips recalled
8 lots of OneTouch SureStep Test Strips have been recalled by their manufacturer LifeScan
(31 KB) Download PDF
English
3/2/2010
Azmacort Inhalation Aerosol discontinued
Azmacort® (triamcinolone acetonide) Inhalation Aerosol discontinued
(36 KB) Download PDF
English
2/23/2010
GlucoPro Insulin Syringes
Nipro Medical Corporation is voluntarily recalling all lots of GlucoPro® insulin syringes.
(41 KB) Download PDF
English
2/2/2010
GlucoPro®Insulin Syringes Recalled
GlucoPro Insulin Syringes Recalled by its manufacturer Nipro Medical Corporation
(45 KB) Download PDF
English
12/29/2009
Sanofi Pasteur H1N1 Pediatric Vaccine in Pre-Filled Syringes Recalled
Sanofi Pasteur has issued a non-safety related voluntarily recall of certain lots of H1N1 Pediatric (0.25 ml, for 6-35 months old) vaccine in pre-filled syringes.
(36 KB) Download PDF
English
11/3/2009
Accusure Insulin Syringes Recalled
Qualitest Pharmaceuticals, Inc. is voluntarily recalling all lots of Accusure Insulin Syringes.
(27 KB) Download PDF
English
9/2/2009
Accusure Insulin Syringes Recall
Specific lots of Accusure®Insulin Syringes have been recalled by its manufacturer Qualitest Pharmaceuticals, Inc.
(27 KB) Download PDF
English
8/20/2009
Dextroamphetamine/Amphetamine 20mg Tablets Recall
Dextroamphetamine/Amphetamine 20mg tablets have been recalled by its manufacturer Barr Laboratories
(27 KB) Download PDF
English
8/11/2009
Casodex is Now Generic
On 7/1/09 Casodex became available in generic form
(27 KB) Download PDF
English
8/4/2009
BD Luer Lok Syringes
BD Luer Lok Syringes have been recalled by its manufacturer Becton-Dickenson
(27 KB) Download PDF
English
7/30/2009
Quick-set Infusion Sets
Specific lots of Quick-Set Infusion Sets have been recalled by its manufacturer, Medtronic, Inc.
(34 KB) Download PDF
English
5/12/2009
Topamax is Now Generic
On 4/1/09 TOPAMAX became available in generic form
(300 KB) Download PDF
English
4/7/2009
Digoxin 0.125 mg and 0.25 mg Tablets
Caraco Pharmaceutical Laboratories, Ltd., voluntarily recalls all lots of Digoxin tablets due to size variability
(300 KB) Download PDF
English
3/26/2009
Propafenone 225 mg Tablets
Watson Laboratories voluntarily recalls one lot due to the potential presence of oversized tablets
(300 KB) Download PDF
English
12/23/2008
CFC-Propelled Albuterol Inhalers
CFC-Propelled Albuterol Inhalers will not be Available Starting January 1, 2009
(300 KB) Download PDF
English
12/23/2008
Multiple Medications by ETHEX Corp. Recalled
Six medications have been recalled due to the potential presence of oversized tablets
(300 KB) Download PDF
English
12/4/2008
ReliOn Insulin Syringes - Medical Device Recall
Mislabeled syringes may lead to an overdose of as much as 2.5 times the intended dose
(300 KB) Download PDF
English
10/15/2008
Dextroamphetamine Sulfate 5 mg Tablets
ETHEX Corp. voluntarily recalls three lots due to the potential presence of oversized tablets
(300 KB) Download PDF
English

Supplemental Insurance

Financial Protection

Financial Protection Plans

Humana offers life & supplemental insurance options that are affordable, simple to understand, and easy to obtain.